Comparative Pharmacology
Head-to-head clinical analysis: COLYTE WITH FLAVOR PACKS versus CONSTILAC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: COLYTE WITH FLAVOR PACKS versus CONSTILAC.
COLYTE WITH FLAVOR PACKS vs CONSTILAC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Colyte is an isotonic solution containing polyethylene glycol 3350 and electrolytes. It acts as an osmotic laxative by retaining water in the colon through non-absorbable polyethylene glycol, resulting in bowel evacuation. The electrolytes prevent significant fluid and electrolyte shifts.
Constilac (lactulose) is a synthetic disaccharide that is not absorbed in the small intestine. In the colon, it is metabolized by bacteria to short-chain fatty acids (e.g., lactic acid), which osmotically draw water into the bowel, producing a laxative effect. Additionally, in hepatic encephalopathy, the acidification of colonic contents traps ammonia (NH3) as ammonium (NH4+), reducing its absorption.
Adults: 4 liters of reconstituted solution administered orally or via nasogastric tube at a rate of 240 mL every 10 minutes, given as a single dose or in divided doses for colonoscopy preparation.
Oral, 15-45 mL (10-20 g lactulose) once daily, titrated to produce 2-3 soft stools daily; may be given as a single dose or divided twice daily. Onset of action 24-48 hours.
None Documented
None Documented
Not applicable (non-absorbed; no systemic absorption, thus no elimination half-life in plasma).
Not applicable due to negligible systemic absorption; lactulose acts locally in the colon.
Primarily fecal (100%) as non-absorbed oral solution; negligible renal or biliary elimination.
Primarily fecal as unchanged drug (systemic absorption negligible). Renal excretion accounts for <2% of any absorbed fraction. Biliary excretion is minimal.
Category C
Category C
Osmotic Laxative
Osmotic Laxative